Literature DB >> 1840657

Construction of interleukin-1 alpha mutants using unequal contamination of synthetic oligonucleotides.

K Poindexter1, R Jerzy, R B Gayle.   

Abstract

Proteins without readily available three-dimensional structural data present a difficult problem in the exploration of structure/function relationships. Saturation mutagenesis using contaminated oligonucleotides can identify potentially interesting regions of such a protein. This technique, in which synthesized oligonucleotides contain low-level base substitutions, allows random mutations to be placed throughout a gene sequence. Using double-stranded cassettes, a region of the human interleukin-1 alpha gene has been altered using such mutagenic oligonucleotides. However, instead of contaminating both strands of the gene sequence at the same level, each strand of the insert was contaminated at a different level. Several recombinants were sequenced and the effects of the mutations on the activity of the proteins were examined. Contaminating the two oligonucleotides at different levels produced a significantly different distribution of nucleotide changes from that seen if both strands were contaminated at the same level. The observed distribution followed the average of the distributions for each of the two contamination levels. This resulted in roughly equal frequencies of 1 to 5 nucleotide changes per clone with very few clones containing the wild-type nucleotide sequence. This helped overcome the redundancy in the genetic code, resulting in a high frequency of amino acid changes, and allowed changes at every amino acid to be sampled in a small number of mutants. This procedure can allow a gene sequence to be screened rapidly by removing most wild-type sequences from analysis while making sure that there are many amino acid changes in the resultant mutants.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1840657      PMCID: PMC328121          DOI: 10.1093/nar/19.8.1899

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  14 in total

1.  Random oligonucleotide mutagenesis: application to a large protein coding sequence of a major histocompatibility complex class I gene, H-2DP.

Authors:  R Murray; K Pederson; H Prosser; D Muller; C A Hutchison; J A Frelinger
Journal:  Nucleic Acids Res       Date:  1988-10-25       Impact factor: 16.971

Review 2.  The role of computer simulation techniques in protein engineering.

Authors:  W F van Gunsteren
Journal:  Protein Eng       Date:  1988-04

3.  Identifying determinants of folding and activity for a protein of unknown structure.

Authors:  J U Bowie; R T Sauer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

4.  Saccharomyces cerevisiae CYC1 mRNA 5'-end positioning: analysis by in vitro mutagenesis, using synthetic duplexes with random mismatch base pairs.

Authors:  J B McNeil; M Smith
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

5.  Genetic studies of the lac repressor. III. Additional correlation of mutational sites with specific amino acid residues.

Authors:  C Coulondre; J H Miller
Journal:  J Mol Biol       Date:  1977-12-15       Impact factor: 5.469

6.  A point mutation uncouples human interleukin-1 beta biological activity and receptor binding.

Authors:  L Gehrke; S A Jobling; L S Paik; B McDonald; L J Rosenwasser; P E Auron
Journal:  J Biol Chem       Date:  1990-04-15       Impact factor: 5.157

7.  A human IL-1 alpha derivative which lacks prostaglandin E2 inducing activity and inhibits the activity of IL-1 through receptor competition.

Authors:  M Yamayoshi; M Ohue; H Kawashima; H Kotani; M IIda; S Kawata; M Yamada
Journal:  Lymphokine Res       Date:  1990

8.  Cloning, sequence and expression of bovine interleukin 1 alpha and interleukin 1 beta complementary DNAs.

Authors:  C R Maliszewski; P E Baker; M A Schoenborn; B S Davis; D Cosman; S Gillis; D P Cerretti
Journal:  Mol Immunol       Date:  1988-05       Impact factor: 4.407

9.  Determination of the minimum polypeptide lengths of the functionally active sites of human interleukins 1 alpha and 1 beta.

Authors:  B Mosley; S K Dower; S Gillis; D Cosman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

10.  The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor.

Authors:  B Mosley; D L Urdal; K S Prickett; A Larsen; D Cosman; P J Conlon; S Gillis; S K Dower
Journal:  J Biol Chem       Date:  1987-03-05       Impact factor: 5.157

View more
  3 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

3.  Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor.

Authors:  E Labriola-Tompkins; C Chandran; K L Kaffka; D Biondi; B J Graves; M Hatada; V S Madison; J Karas; P L Kilian; G Ju
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.